Do the US elections set the COVID-19 vaccine phase on fire? – DVO



[ad_1]

The White House on Sept. 1 denied the World Health Organization (WHO) concerns regarding the COVID-19 vaccine announcement process.

Has the United States completed the COVID-19 vaccine period?
The United States dismisses the WHO’s concerns about the COVID-19 vaccine.

Consequently, White House spokesman Judd Deere has said that the United States will not be constrained by the World Health Organization and China.

“The United States will continue to attract international partners to ensure the defeat of the COVID-19 epidemic, but we will not be limited by multilateral organizations influenced by the World Health Organization and China. The system will spare no expense to ensure that any new vaccine uphold the US Food and Drug Administration (FDA) gold standard for safety, efficacy, scrutiny, and citizen salvage. “

The statement comes after Mike Ryan, head of the WHO emergency program, warned of the possibility of the FDA shortening the COVID-19 vaccine announcement process.

“If we go to vaccinate millions of people too quickly, we could ignore certain side effects,” he said.

The previous day, FDA leader Stephen Hahn announced that the FDA was preparing to authorize a COVID-19 vaccine before phase 3 clinical trials were completed, as long as US officials take a beating. the price that the benefits of the vaccine outweigh the risks.

Hahn also did not express a clear attitude on the possibility that the FDA, under pressure from US President Donald Trump, will shorten the procedures for the announcement of the COVID-19 vaccine.

Since August, Trump has been open to considering circumventing normal US standards to speed up the licensing process for a COVID-19 vaccine to be used in the US prior to the general election. system in 2020.

This option would include the United States Food and Drug Administration (FDA) issuing an “emergency use license” for such a vaccine.

Observers said the decision to ask the FDA to shorten the process of announcing Trump’s vaccine was to gain an advantage over his rival, the Democratic Party Joe Biden. This is dangerous, as reducing COVID-19 vaccine screening procedures could result in side effects not being fully calculated. Trump’s publication of an “ultimatum” to the COVID-19 vaccine also contradicts his views since Russia announced the world’s first COVID-19 vaccine.

Washington has seen a move to advertise a vaccine in a “national emergency” as unsafe, while the US president has expressed that he “hopes the vaccine will be effective.”

Advising the US President during the COVID-19 pandemic, US leading health expert Dr. Anthony Fauci warned the country not to rush to quickly review a COVID-19 vaccine before it is proven safe. complete and efficient.

Meanwhile, the Russian COVID-19 vaccine has developed rapidly and is ahead of the world not only because of the shortening of the trial period, but also because of the scientific results that lasted decades.

This is a medical product that follows the results of this country’s scientific research since the 1950s. Russian scientists have emphasized that the results of the current vaccine are due to its “well-preserved heritage”, which the country’s laboratory It continues to focus on virology, while the rest of the world has flocked to molecular biology.

Despite doubts about the quality of Russia’s COVID-19 vaccine, 20 countries are believed to have pre-ordered more than 1 billion doses of Sputnik V, possibly for believing in a rich history of virology. and the development of Russian vaccines since the time of the Soviet Union. In the 1950s, members of the Soviet Union played an essential role in the early production and initial testing of Albert Sabin’s oral polio vaccine.

The Soviet Union is also the country that gave the World Health Organization more smallpox vaccines than all other countries combined during the eradication campaign of the 1960s and 1970s, with a special freeze-drying technique, which provided good results. The high temperature setting of the vaccine facilitates its use in tropical climates.

Hai Lam



[ad_2]